{"id":177421,"date":"2011-01-18T00:00:00","date_gmt":"2011-01-17T23:00:00","guid":{"rendered":"https:\/\/hwpd.bcfi-cbip.be\/symbole-en-regard-des-specialites-contenant-un-nouveau-principe-actif-liste-des-medicaments-janvier-2011\/"},"modified":"2026-04-13T11:34:28","modified_gmt":"2026-04-13T09:34:28","slug":"symbole-en-regard-des-specialites-contenant-un-nouveau-principe-actif-liste-des-medicaments-janvier-2011","status":"publish","type":"post","link":"https:\/\/hwpd.bcfi-cbip.be\/fr\/symbole-en-regard-des-specialites-contenant-un-nouveau-principe-actif-liste-des-medicaments-janvier-2011\/","title":{"rendered":"Symbole\u00a0\u00a0en regard des sp\u00e9cialit\u00e9s contenant un nouveau principe actif: liste des m\u00e9dicaments\u00a0janvier 2011"},"content":{"rendered":"<div class='tekst'>\n<p class='MsoNormal' style='margin: 0in 0in 0pt; line-height: 150%'><span><span lang='FR' style='font-size: 10pt; line-height: 150%; font-family: Arial; mso-ansi-language: FR'>\u00a0<\/span><\/span><span lang='FR' style='mso-ansi-language: FR'><\/p>\n<p\/><\/span><\/p>\n<p\/>\n<p class='MsoNormal' style='margin: 0in 0in 0pt; line-height: 150%'><span><span lang='FR' style='font-size: 10pt; line-height: 150%; font-family: Arial; mso-ansi-language: FR'>Afin d\u2019attirer davantage l\u2019attention sur les sp\u00e9cialit\u00e9s contenant un nouveau principe actif&#x002C; le symbole\u00a0<img height='10' alt='' width='10' border='0' src='\/images\/surv.gif'\/><\/span><span lang='FR' style='mso-ansi-language: FR'><font face='Times New Roman' size='3'>\u00a0<\/font><\/span><span lang='FR' style='font-size: 10pt; line-height: 150%; font-family: Arial; mso-ansi-language: FR'> est\u00a0plac\u00e9 dans le R\u00e9pertoire Comment\u00e9 des M\u00e9dicaments en regard de ces sp\u00e9cialit\u00e9s pendant les 3 premi\u00e8res ann\u00e9es suivant leur <personname w:st='on'>commercialisation<\/personname> [<a target='_blank' href='http:\/\/www.cbip.be\/Folia\/2007\/F34F12G.cfm'>voir Folia de d\u00e9cembre 2007<\/a>]. Par ce symbole&#x002C; le Centre de Pharmacovigilance de l\u2019Agence F\u00e9d\u00e9rale des M\u00e9dicaments et des Produits de Sant\u00e9 (AFMPS) d\u00e9sire inciter les m\u00e9decins et pharmaciens \u00e0 notifier toute suspicion d\u2019effet ind\u00e9sirable avec ces m\u00e9dicaments&#x002C; m\u00eame en cas de doute quant \u00e0 la relation de causalit\u00e9.<span> <span style='mso-spacerun: yes'>\u00a0<\/span><\/span><\/span><\/span><span lang='FR' style='mso-ansi-language: FR'><\/p>\n<p\/><\/span><\/p>\n<p\/>\n<p class='MsoNormal' style='margin: 0in 0in 0pt; line-height: 150%'><span><span lang='FR' style='font-size: 10pt; line-height: 150%; font-family: Arial; mso-ansi-language: FR'>\u00a0<\/span><\/span><span lang='FR' style='mso-ansi-language: FR'><\/p>\n<p\/><\/span><\/p>\n<p\/>\n<p><span lang='FR' style='font-size: 10pt; font-family: Arial; mso-ansi-language: FR; mso-fareast-language: NL'><\/p>\n<p\/><span>La liste des m\u00e9dicaments concern\u00e9s par le symbole\u00a0 <img height='10' alt='' width='10' border='0' src='\/images\/surv.gif'\/>\u00a0dans le R\u00e9pertoire (version\u00a0d\u00e9cembre 2010)\u00a0peut \u00eatre consult\u00e9e via : <font color='#800080'><a href='\/userfiles\/file\/M\u00e9d%20black%20triangle%20FR%2010012011.pdf'>Liste des nouveaux m\u00e9dicaments portant le symbole<\/a> <\/font><span style='text-decoration: none; text-underline: none'><img height='10' alt='' width='10' border='0' src='\/images\/surv.gif'\/><\/span><font color='#800080'>\u00a0\u00a0<\/font><\/span><\/span><span lang='FR' style='font-size: 10pt; font-family: Arial; mso-ansi-language: FR'><\/p>\n<p\/><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0 Afin d\u2019attirer davantage l\u2019attention sur les sp\u00e9cialit\u00e9s contenant un  [&#8230;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,52],"tags":[20213,20224],"class_list":["post-177421","post","type-post","status-publish","format-standard","hentry","category-actualites","category-2011-fr","tag-import_tags","tag-import_tags-nl"],"_links":{"self":[{"href":"https:\/\/hwpd.bcfi-cbip.be\/fr\/wp-json\/wp\/v2\/posts\/177421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hwpd.bcfi-cbip.be\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hwpd.bcfi-cbip.be\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hwpd.bcfi-cbip.be\/fr\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/hwpd.bcfi-cbip.be\/fr\/wp-json\/wp\/v2\/comments?post=177421"}],"version-history":[{"count":1,"href":"https:\/\/hwpd.bcfi-cbip.be\/fr\/wp-json\/wp\/v2\/posts\/177421\/revisions"}],"predecessor-version":[{"id":179995,"href":"https:\/\/hwpd.bcfi-cbip.be\/fr\/wp-json\/wp\/v2\/posts\/177421\/revisions\/179995"}],"wp:attachment":[{"href":"https:\/\/hwpd.bcfi-cbip.be\/fr\/wp-json\/wp\/v2\/media?parent=177421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hwpd.bcfi-cbip.be\/fr\/wp-json\/wp\/v2\/categories?post=177421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hwpd.bcfi-cbip.be\/fr\/wp-json\/wp\/v2\/tags?post=177421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}